ByTrending Posts
Can Valo Health and nference’s AI Alliance Reshape…
Key Insights for Industry Leaders A Strategic Union to Redefine Biopharma R&DValo Health and nference have joined forces…
How Are Charles River and Valo Health Leveraging…
Key Highlights:• Charles River and Valo Health identify the first Logica®-powered therapeutic candidate targeting lupus and autoimmune diseases…
How Pfizer and Flagship Pioneering Are Using AI…
Key Highlights Strategic Collaboration with a Transformative Goal Flagship Pioneering has announced a new collaboration between its in-house…
How Median Technologies AI Set to Transform Global…
Key Highlights AI-Powered Innovation in Oncology ImagingMedian Technologies, a pioneer in AI-driven medical imaging, will showcase its eyonis®…
NVIDIA CEO Jensen Huang Unveils Vision of a…
Key Highlights At COMPUTEX 2025 in Taipei, NVIDIA founder and CEO Jensen Huang revealed a groundbreaking vision positioning…
How LIS Technologies Is Advancing Medical Isotope Production…
Key Highlights Innovative CRISLA Technology to Impact Medical Therapies The company’s proprietary Condensation Repression Isotope Selective Laser Activation…
How Eli Lilly-Backed Persist AI Secured $12M to…
Key highlights Persist AI, a healthcare deep tech startup based in Sacramento, CA, has successfully raised $12 million…
How Is WorkDoneAI Transforming Healthcare Documentation Compliance with…
Key Highlights of WorkDone’s $1.8M Seed Funding: San Francisco, CA – WorkDone, a Y Combinator-backed healthcare AI startup,…
How Is TrialMatchAI from Bordeaux Bioinformatics Center Revolutionizing…
Key Highlights: The Bordeaux Bioinformatics Center, in collaboration with the EOSC4Cancer initiative, has unveiled TrialMatchAI, an advanced AI-driven…
Trending Posts
Latest Stories
Is Eli Lilly’s $450 Million AI Investment in 2025 Set to Transform Drug Discovery, R&D, and Commercialization?
Global – December 31, 2025 — Eli Lilly and Company significantly expanded its artificial intelligence…
Is Pfizer’s $500 Million AI Investment in 2025 Poised to Redefine Drug Discovery and Commercialization?
Global – December 31, 2025 — Pfizer Inc. significantly increased investment in artificial intelligence (AI)…
Is Biopharma’s $8.5 Billion AI Investment in 2025 Across Discovery, R&D, and Commercialization Shaping the 2026 Innovation Landscape?
Global – December 31, 2025 — Biopharmaceutical companies significantly increased investment in artificial intelligence (AI)…
Does BioMark’s 2025 Corporate Update Mark the Shift from Clinical Validation to Commercial-Scale Growth in Lung Cancer Diagnostics?
Executive Summary BioMark’s 2025 corporate update marks a decisive inflection point as the company completes…
Gallery
